These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 836500)
61. Ergot alkaloids. Synthesis of nitrosourea derivatives of ergolines as potential anticancer agents. Crider AM; Lu CK; Floss HG; Cassady JM; Clemens JA J Med Chem; 1979 Jan; 22(1):32-5. PubMed ID: 423180 [TBL] [Abstract][Full Text] [Related]
62. A new class of nitrosoureas. IX. Synthesis and antitumor activity of 3-substituted 1-(2-chloroethyl)-3-(methyl alpha-D-glucopyranosid-6-yl or methyl 2-acetamido-2-deoxy-alpha-D-glucopyranosid-6-yl)-1-nitrosoureas. Morikawa T; Tsujihara K; Takeda M; Arai Y Chem Pharm Bull (Tokyo); 1983 Nov; 31(11):3924-30. PubMed ID: 6671237 [No Abstract] [Full Text] [Related]
63. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas. Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614 [TBL] [Abstract][Full Text] [Related]
64. Chemistry and structure-activity studies of the nitrosoureas. Montgomery JA Cancer Treat Rep; 1976 Jun; 60(6):651-64. PubMed ID: 954007 [TBL] [Abstract][Full Text] [Related]
65. Comparative nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU) and chlorozotocin: functional-structural correlations in the Fischer 344 rat. Kramer RA; Boyd MR; Dees JH Toxicol Appl Pharmacol; 1986 Mar; 82(3):540-50. PubMed ID: 2937179 [TBL] [Abstract][Full Text] [Related]
66. O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea. Brent TP; Houghton PJ; Houghton JA Proc Natl Acad Sci U S A; 1985 May; 82(9):2985-9. PubMed ID: 3857628 [TBL] [Abstract][Full Text] [Related]
67. In the search for new anticancer drugs. 28. Synthesis and evaluation of highly active aminoxyl labeled amino acid derivatives containing the [N'-(2-chloroethyl)-N'-nitrosoamino]carbonyl group. Sosnovsky G; Baysal M; Erciyas E J Pharm Sci; 1994 Jul; 83(7):999-1005. PubMed ID: 7965680 [TBL] [Abstract][Full Text] [Related]
68. L1210 leukemia i.v. implanted as a model for testing short-chain nitrosourea analogs. Schmid JR; Fiebig HH; Eisenbrand G; Löhr GW J Cancer Res Clin Oncol; 1986; 111(1):31-4. PubMed ID: 3949848 [TBL] [Abstract][Full Text] [Related]
69. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides. Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382 [TBL] [Abstract][Full Text] [Related]
70. Antitumor effect of pyridine N-oxides having 1-(2-chloroethyl)-1-nitrosoureidoalkyl and 1-methyl-1-nitrosoureidoalkyl groups. Miyahara M; Kamiya S; Maekawa A; Odashima S Gan; 1979 Dec; 70(6):731-6. PubMed ID: 535684 [TBL] [Abstract][Full Text] [Related]
71. In vivo studies on the relationship between hepatic metabolism and the renal toxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU). Kramer RA; McMenamin MG; Boyd MR Toxicol Appl Pharmacol; 1986 Sep; 85(2):221-30. PubMed ID: 3764909 [TBL] [Abstract][Full Text] [Related]
72. Effects of buthionine sulfoximine on the nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU). Kramer RA; Schuller HM; Smith AC; Boyd MR J Pharmacol Exp Ther; 1985 Aug; 234(2):498-506. PubMed ID: 4020683 [TBL] [Abstract][Full Text] [Related]
73. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia. Hansch C; Leo A; Schmidt C; Jow PY; Montgomery JA J Med Chem; 1980 Oct; 23(10):1095-101. PubMed ID: 7420354 [TBL] [Abstract][Full Text] [Related]
74. A new class of nitrosoureas. VIII. Synthesis and antitumor activity of 3-substituted 1-(2-chloroethyl)-3-(trans-2-hydroxycyclohexyl)-1-nitrosoureas. Morikawa T; Tsujihara K; Takeda M; Arai Y Chem Pharm Bull (Tokyo); 1983 May; 31(5):1646-51. PubMed ID: 6616712 [No Abstract] [Full Text] [Related]
75. A new class of nitrosoureas. VI. Synthesis and antitumor activity of 3-substituted-1-(2-chloroethyl)-3-(methyl-alpha-D-glucopyranosid-2-yl)-1-nitrosoureas. Morikawa T; Takeda M; Arai Y; Tsujihara K Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2386-92. PubMed ID: 7139813 [No Abstract] [Full Text] [Related]
76. Mutagenicity of nitrosourea compounds for Salmonella typhimurium. Auletta AE; Martz AG; Parmar AS J Natl Cancer Inst; 1978 Jun; 60(6):1495-7. PubMed ID: 349171 [TBL] [Abstract][Full Text] [Related]
77. Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma. Montgomery JA; McCaleb GS; Johnston TP; Mayo JG; Laster WR J Med Chem; 1977 Feb; 20(2):291-5. PubMed ID: 836501 [TBL] [Abstract][Full Text] [Related]
78. Nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU) in the Fischer 344 rat. Kramer RA; Boyd MR J Pharmacol Exp Ther; 1983 Nov; 227(2):409-14. PubMed ID: 6631721 [TBL] [Abstract][Full Text] [Related]
79. Noval antitumor nitrosoureas and related compounds and their reactions with DNA. Lown JW; Joshua AV; McLaughlin LW J Med Chem; 1980 Jul; 23(7):798-805. PubMed ID: 7401107 [No Abstract] [Full Text] [Related]
80. Preparation of N'-substituted anilino-N-methyl-N'nitrosoureas as candidate antitumor agents. Kim JC; Lim YG; Min BT; Park JI Arch Pharm Res; 1994 Dec; 17(6):420-3. PubMed ID: 10319151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]